VERX vs. KRYS
Compare and contrast key facts about Vertex, Inc. (VERX) and Krystal Biotech, Inc. (KRYS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VERX or KRYS.
Correlation
The correlation between VERX and KRYS is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VERX vs. KRYS - Performance Comparison
Loading data...
Key characteristics
VERX:
0.46
KRYS:
-0.30
VERX:
0.98
KRYS:
-0.22
VERX:
1.15
KRYS:
0.97
VERX:
0.51
KRYS:
-0.40
VERX:
1.29
KRYS:
-0.88
VERX:
18.74%
KRYS:
17.30%
VERX:
43.02%
KRYS:
43.96%
VERX:
-75.40%
KRYS:
-53.42%
VERX:
-35.66%
KRYS:
-37.04%
Fundamentals
VERX:
$5.93B
KRYS:
$4.03B
VERX:
-$0.29
KRYS:
$4.17
VERX:
8.63
KRYS:
12.08
VERX:
29.57
KRYS:
4.09
VERX:
$687.06M
KRYS:
$333.45M
VERX:
$436.53M
KRYS:
$308.79M
VERX:
$75.68M
KRYS:
$130.03M
Returns By Period
In the year-to-date period, VERX achieves a -28.90% return, which is significantly lower than KRYS's -14.13% return.
VERX
-28.90%
-1.43%
-23.76%
19.65%
N/A
N/A
KRYS
-14.13%
-18.47%
-28.14%
-13.11%
17.95%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VERX vs. KRYS — Risk-Adjusted Performance Rank
VERX
KRYS
VERX vs. KRYS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vertex, Inc. (VERX) and Krystal Biotech, Inc. (KRYS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
VERX vs. KRYS - Dividend Comparison
Neither VERX nor KRYS has paid dividends to shareholders.
Drawdowns
VERX vs. KRYS - Drawdown Comparison
The maximum VERX drawdown since its inception was -75.40%, which is greater than KRYS's maximum drawdown of -53.42%. Use the drawdown chart below to compare losses from any high point for VERX and KRYS. For additional features, visit the drawdowns tool.
Loading data...
Volatility
VERX vs. KRYS - Volatility Comparison
The current volatility for Vertex, Inc. (VERX) is 8.12%, while Krystal Biotech, Inc. (KRYS) has a volatility of 18.92%. This indicates that VERX experiences smaller price fluctuations and is considered to be less risky than KRYS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
VERX vs. KRYS - Financials Comparison
This section allows you to compare key financial metrics between Vertex, Inc. and Krystal Biotech, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VERX vs. KRYS - Profitability Comparison
VERX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Vertex, Inc. reported a gross profit of 112.99M and revenue of 177.06M. Therefore, the gross margin over that period was 63.8%.
KRYS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Krystal Biotech, Inc. reported a gross profit of 83.16M and revenue of 88.18M. Therefore, the gross margin over that period was 94.3%.
VERX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Vertex, Inc. reported an operating income of 4.49M and revenue of 177.06M, resulting in an operating margin of 2.5%.
KRYS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Krystal Biotech, Inc. reported an operating income of 36.18M and revenue of 88.18M, resulting in an operating margin of 41.0%.
VERX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Vertex, Inc. reported a net income of 11.13M and revenue of 177.06M, resulting in a net margin of 6.3%.
KRYS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Krystal Biotech, Inc. reported a net income of 35.73M and revenue of 88.18M, resulting in a net margin of 40.5%.